Cited by 244Chromatin Remodeling and CancerProtein Degradation and InhibitorsGenomics and Chromatin Dynamics

Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers

Papillon, Julien P. N., Nakajima, Katsumasa, Adair, Christopher D., Hempel, Jonathan, Jouk, Andriana O., Karki, Rajeshri G., Mathieu, Simon, Möbitz, Henrik +28 more·2018·Journal of Medicinal Chemistry

Abstract

SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily A member 2 (SMARCA2), also known as Brahma homologue (BRM), is a Snf2-family DNA-dependent ATPase. BRM and its close homologue Brahma-related gene 1 (BRG1), also known as SMARCA4, are mutually exclusive ATPases of the large ATP-dependent SWI/SNF chromatin-remodeling complexes involved in transcriptional regulation of gene expression. No small molecules have been reported that modulate SWI/SNF chromatin-remodeling activity via inhibition of its ATPase activity, an important goal given the well-established dependence of BRG1-deficient cancers on BRM. Here, we describe allosteric dual BRM and BRG1 inhibitors that downregulate BRM-dependent gene expression and show antiproliferative activity in a BRG1-mutant-lung-tumor xenograft model upon oral administration. These compounds represent useful tools for understanding the functions of BRM in BRG1-loss-of-function settings and should enable probing the role of SWI/SNF functions more broadly in different cancer contexts and those of other diseases.

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.8b01318

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Papillon, J. P. N., Nakajima, K., Adair, C. D., Hempel, J., Jouk, A. O., Karki, R. G., Mathieu, S., Möbitz, H., Ntaganda, R., Smith, T., Visser, M., Hill, S. E., Hurtado, F. K., Chenail, G., Bhang, H.-E. C., Bric, A., Xiang, K., Bushold, G., Gilbert, T., Vattay, A., Dooley, J., Costa, E. A., Park, I., Li, A., Farley, D., Lounkine, E., Yue, Q. K., Xie, X., Zhu, X., Kulathila, R., King, D., Hu, T., Vulic, K., Cantwell, J., Luu, C., & Jagani, Z.
Affiliations
  • Novartis (Switzerland) (CH)
  • Novartis (United States) (US)
  • Novartis Institutes for Biomedical Research, 5300 Chiron Way, Emeryville, California 94608, United States
Corresponding author
Papillon, Julien P. N.
Venue
Journal of Medicinal Chemistry
Published
2018-10-19
Volume
61
Issue
22
Pages
10155-10172
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W2899982406
Cited by
244
References
36
Citations by year
2026: 31 · 2025: 53 · 2024: 51 · 2023: 37 · 2022: 21 · 2021: 20 · 2020: 19 · 2019: 11
FWCI
4.42
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
BRM, SMARCA2, SMARCA4, SWI/SNF complex, ATPase inhibitors, allosteric inhibitors, lung cancer, oral bioavailability, antiproliferative activity, gene expression regulation
MeSH terms
Administration, Oral, Animals, Antineoplastic Agents, DNA Helicases, Dose-Response Relationship, Drug, Humans, Models, Molecular, Mutation, Nuclear Proteins, Protein Conformation, Structure-Activity Relationship, Transcription Factors, Drug Design, Xenograft Model Antitumor Assays, Cell Line, Tumor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review